- ►annals.org M Hjorth, J Westin, IMS Dahl, P Gimsing, E … - Annals of Internal Medicine, 1996 - Am Coll Physicians Intervention: All patients received melphalan-prednisone every 6 weeks.
Melphalan-prednisone therapy was interrupted after at least 8 courses in
responding patients who achieved a plateau phase, and it was reinstituted ... Cited by 17 - Related articles - All 3 versions
A Waage, P Gimsing, G Juliusson, I Turesson, … - British journal of haematology, 2004 - interscience.wiley.com Sixty-five patients who were primary or secondary refractory to
melphalan/prednisone or other type of chemotherapy, or relapsed within 6 months
after high dose chemotherapy with stem cell support, were given thalidomide ... Cited by 18 - Related articles - BL Direct - All 6 versions
N Gulbrandsen, F Wisloff, E Nord, S Lenhoff, M … - European journal of haematology, 2001 - interscience.wiley.com Abstract: We evaluated the costs and the cost utility of high-dose melphalan and
autologous stem cell support followed by interferon maintenance relative to
conventional treatment with melphalan and prednisone, in patients less than ... Cited by 18 - Related articles - BL Direct - All 6 versions
F WislOff, M Hjorth, S Kaasa, J Westin - British Journal of Haematology, 1996 - interscience.wiley.com In a Nordic multi-centre trial, 583 previously untreated multiple myeloma
patients were randomized to receive melphalan–prednisone or
melphalan–prednisone + interferon α-2b at a dose of 5 million units ... Cited by 56 - Related articles - BL Direct - All 4 versions
E Nord, F Wisløff, M Hjorth, J Westin - Pharmacoeconomics, 1997 - ncbi.nlm.nih.gov This study evaluated the cost utility of adding interferon-alpha 2b to
conventional treatment in patients with multiple myeloma. It also provides a
methodology for transforming complex quality-of-life profiles into a single ... Cited by 29 - Related articles - BL Direct - All 3 versions
N Gulbrandsen, MJ Hjermstad, F Wisloff - European journal of haematology, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 19 - Related articles - BL Direct - All 4 versions
[CITATION] Nordic Myeloma Study Group (2004) Interpretation of quality of life scores in multiple …
